(Q40082252)

English

Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies

scientific article published on 11 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Andreas Wortmann

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sabine Vöhringer

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Tatjana Engler

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Stephanie Corjon

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Reinhold Schirmbeck

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Jörg Reimann

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Stefan Kochanek

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Florian Kreppel

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

154-162

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

The liver as a site of T-cell apoptosis: graveyard, or killing field?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300306

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.MT.6300306

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40082252&oldid=1884624292"